Drug Delivery with Targeted Nanoparticles

In Vitro and In Vivo Evaluation Methods
Herausgeber: Çapan, Y¿lmaz; Tonbul, Hayrettin; Sahin, Adem

• Gebundenes Buch

Produktbeschreibung

This book discusses the production, characterization, regulation, and currently marketed targeted nanoparticle systems in a broad framework.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Jenny Stanford Publishing
• Seitenzahl: 790
• Erscheinungstermin: 30. November 2021
• Englisch
• Abmessung: 235mm x 157mm x 46mm
• Gewicht: 1274g
• ISBN-13: 9789814877756
• ISBN-10: 9814877751
• Artikelnr.: 62506037

Autorenporträt

Y¿lmaz Çapan is Professor and Head of the Pharmaceutical Technology Department, Faculty of Pharmacy, Hacettepe University, Turkey. He obtained his bachelor's degree in pharmacy from Hacettepe University in 1972 and PhD with honors from the University of Lille, Faculty of Pharmacy, France, in 1978. He has authored more than 80 publications in prestigious, refereed pharmaceutical science journals, with a current citation number of more than 2000, and 3 books. Prof. Çapan is a member of the American Association of Pharmaceutical Scientists, the Association of Pharmaceutical Sciences of Ankara, the Turkish Pharmacists' Association, and the Pharmacist's Chamber of Ankara. His research interests include tabletting sustainedrelease oral solid dosage forms, bioadhesion, protein delivery from biodegradable microspheres, and brain drug targeting. Adem Sahin is Assistant Professor at the Faculty of Pharmacy, Selçuk University, Turkey. He obtained his bachelor's degree in pharmacy from Erciyes University, Turkey, in 2011 and PhD with honors from the Department of Pharmaceutical Technology, Hacettepe University, in 2017. He has been working in the pharmaceutical industry as a formulation specialist and a clinical trials executive and his research interests include brain drug delivery, cancer nanomedicine, and nanotechnology in drug delivery. Hayrettin Tonbul is Assistant Professor at the Faculty of Pharmacy, ¿nönü University, Turkey. He obtained his bachelor's degree in pharmacy from Near East University, Turkey, in 2015 and PhD with honors from the Department of Pharmaceutical Technology, Hacettepe University, in 2019. His research interests include controlled and targeted drug delivery, cancer nanomedicine, and nanotechnology in drug delivery.

Inhaltsangabe

1. Particle Size Determination of Targeted Nanoparticles 2. Zeta Potential
Determination of Targeted Nanoparticles 3. Stability of Targeted
Nanoparticles 4. Impact of PEGylation on Targeted Nanoparticulate Delivery
5. Ligands and Receptors for Targeted Delivery of Nanoparticles: Recent
Updates and Challenges 6. Characterization of Biological Molecule-Loaded
Nanostructures Using Circular Dichroism and Fourier Transform Infrared
Spectroscopy 7. Evaluation of Stimuli-Sensitive Nanoparticles in vitro 8.
Analytical Techniques for Characterization of Nanodrugs 9. Cytotoxicity and
Biological Compatibility 10. Cellular Uptake and Transcytosis 11.
Evaluation of 3D Cell Culture Models for Efficacy Determination of
Anticancer Nanotherapeutics 12. In vitro and in vivo Blood-Brain Barrier
Models for the Evaluation of Drug Transport with Targeted Nanoparticles 13.
Sterility Evaluation of Targeted Nanoparticles 14. Evaluation of
Pharmacokinetics and Biodistribution of Targeted Nanoparticles 15.
Evaluation of the in vivo Preclinical Toxicity of Targeted Nanoparticles
16. Transdermal Delivery of Targeted Nanoparticles and in vitro Evaluation
17. In vivo and in vitro Evaluation of Nose-to-Brain Delivery of
Nanoparticles 18. Evaluation of Targeted Nanoparticles for Ocular Delivery
19. Vaginally Applied Nanocarriers and Their Characterizations 20. Oral
Administration of Nanoparticles and Approaches for Design, Evaluation, and
State of the Art 21. Drug Resistance Mechanisms and Strategies to Overcome
Drug Resistance with Nanoparticulate Systems 22. Clinical Trials of
Targeted Nanoparticulate Drug Delivery Systems 23. Evaluation of Targeted
Mesoporous Silica Nanoparticles 24. Evaluation of Targeted Liposomes 25.
Prospects of Nanomedicine with Nanocrystal Technology 26. Characteristics
of Marketed Nanopharmaceutics 27. Regulatory Guidelines of the US Food and
Drug Administration and the European Medicines Agency for Actively Targeted
Nanomedicines